> 首页 > 产品 > 一抗 > 其他 > Anti-AXL / UFO Reference Antibody (Bluebird Bio patent anti-CD79A CAR)

Anti-AXL / UFO Reference Antibody (Bluebird Bio patent anti-CD79A CAR)

Anti-CD79A Reference Antibody (Bluebird Bio patent anti-CD79A CAR) on SDS-PAGE under reducing (R) condition. The purity of the protein is greater than 95%.
The purity of Anti-AXL / UFO Reference Antibody (Bluebird Bio patent anti-CD79A CAR) is 100%, determined by SEC-HPLC.
Immobilized Human CD79A, HisTag at 2 µg/mL can bind Bluebird Bio patent anti-CD79A CAR, EC50= 0.02035 µg/mL.

产品详情
实验流程

Product Information
Application Applications Legend: E=ELISA WB=Western Blotting IHC=Immunohistochemistry IHC-P=Immunohistochemistry (Paraffin) IP=Immunoprecipitation IF=Immunofluorescence IC=Immunochemistry ICC=Immunocytochemistry FC=Flow Cytometry DB=Dot Blot	Functional assay, Kinetics (SPR), Kinetics (BLI), FACS, E, FTA
Primary Accession	P11912
Reactivity	Human
Clonality	Monoclonal
Isotype	IgG1
Calculated MW	25038 Da

Additional Information
Target/Specificity	CD79a
Expression system	CHO

For Research Use Only. Not For Use In Diagnostic Procedures.

Patent Notice: The variable region sequence of this antibody is derived from a published third-party patent. This product is manufactured independently as a Research Use Only (RUO) reagent and is not licensed, sponsored, or endorsed by the patent holder. It is intended solely for research purposes. Customers considering any commercial, diagnostic, or therapeutic use should independently evaluate freedom-to-operate with respect to relevant third-party patents.

Protein Information
Name	CD79A
Synonyms	IGA, MB1
Function	Required in cooperation with CD79B for initiation of the signal transduction cascade activated by binding of antigen to the B- cell antigen receptor complex (BCR) which leads to internalization of the complex, trafficking to late endosomes and antigen presentation. Also required for BCR surface expression and for efficient differentiation of pro- and pre-B-cells. Stimulates SYK autophosphorylation and activation. Binds to BLNK, bringing BLNK into proximity with SYK and allowing SYK to phosphorylate BLNK. Also interacts with and increases activity of some Src-family tyrosine kinases. Represses BCR signaling during development of immature B- cells.
Cellular Location	Cell membrane; Single-pass type I membrane protein. Note=Following antigen binding, the BCR has been shown to translocate from detergent-soluble regions of the cell membrane to lipid rafts although signal transduction through the complex can also occur outside lipid rafts.
Tissue Location	B-cells.

Research Areas

Application Protocols

Provided below are standard protocols that you may find useful for product applications.

Western Blot Protocol

Blocking Peptides Protocol

Dot Blot Protocol

Immunohistochemistry Protocol

Immunofluorescence Protocol

Immunoprecipitation Protocol

Flow Cytomety Protocol

Cell Culture Protocol